Newsbenzinga
Labcorp Reaffirms 2026–2029 Long-Term Outlook Following CMS Preliminary Medicare Payment Rate Release; Expects Compound Annual Adj EPS Growth Of 8.5%-11.5% In 2026-2029
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…